Key Points Non-GAAP earnings per share reached $0.52 for Q2 2025, beating expectations by $0.01, but revenue (GAAP) fell 4.9% year over year. US sales declined 18.3% (GAAP), leading to a $214 million ...

Guidance for full-year 2025 product revenue and adjusted EBITDA was increased as prescription growth from ADHD drug Jornay PM accelerates, with prescriptions up 23% year-over-year. These 10 stocks ...

Turnaround progress, improved margins, U.S. manufacturing ramp-up, European gains, and 2025 positive cash flow outlook.

Fortinet shares are trading lower Thursday after the company reported second quarter financial results on Wednesday after the ...

Wayfair sees revenue growth and GAAP profitability in 2025Q2. Learn why W stock upgrade to Hold reflects caution amid ...

Below are the transcripts from the Q2 earnings call. This transcript is brought to you by Benzinga APIs. For real-time access ...

While the company exceeded analyst expectations on several fronts, its Q3 outlook includes softer revenue and a slide back ...

2025 Non-GAAP Guidance: Initiated 2025 non-GAAP guidance at $3.53–$3.65 per share, contingent upon the outcome of the Montana ...

TEGNA expects total revenue to decline 18%-20% year over year in Q3 2025 due to the cyclical absence of political and Summer ...

Separately, the company raised its 2025 target for its Texas Residential Virtual Power Plant (VPP) program from 20 MW to 150 ...